120 related articles for article (PubMed ID: 1587648)
1. Patterns of blood response during cardiopulmonary bypass.
Sundaram S; Irvine L; Courtney JM; Taggart DP; Wheatley DJ; Lowe GD
Int J Artif Organs; 1992 Apr; 15(4):243-8. PubMed ID: 1587648
[TBL] [Abstract][Full Text] [Related]
2. Biocompatibility of cardiopulmonary bypass: influence on blood compatibility of device type, mode of blood flow and duration of application.
Sundaram S; Courtney JM; Taggart DP; Tweddel AC; Martin W; McQuiston AM; Wheatley DJ; Lowe GD
Int J Artif Organs; 1994 Feb; 17(2):118-28. PubMed ID: 8039940
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of factor XII activity and granulocyte elastase release during cardiopulmonary bypass.
Irvine L; Sundaram S; Courtney JM; Taggart DP; Wheatley DJ; Lowe GD
ASAIO Trans; 1991; 37(4):569-71. PubMed ID: 1768490
[TBL] [Abstract][Full Text] [Related]
4. Endotoxemia, complement, and white blood cell activation in cardiac surgery: a randomized trial of laxatives and pulsatile perfusion.
Taggart DP; Sundaram S; McCartney C; Bowman A; McIntyre H; Courtney JM; Wheatley DJ
Ann Thorac Surg; 1994 Feb; 57(2):376-82. PubMed ID: 8311599
[TBL] [Abstract][Full Text] [Related]
5. [Activation of complement and serial changes of anaphylatoxin (C3a, C5a) in patients for open-heart surgery using a membrane oxygenator].
Mitsuhata H; Enzan K; Hasegawa J; Matumoto S; Matsumoto J; Kurosawa S
Masui; 1992 Feb; 41(2):194-9. PubMed ID: 1552659
[TBL] [Abstract][Full Text] [Related]
6. Pressure drop, shear stress, and activation of leukocytes during cardiopulmonary bypass: a comparison between hollow fiber and flat sheet membrane oxygenators.
Gu YJ; Boonstra PW; Graaff R; Rijnsburger AA; Mungroop H; van Oeveren W
Artif Organs; 2000 Jan; 24(1):43-8. PubMed ID: 10677156
[TBL] [Abstract][Full Text] [Related]
7. [Use of cardiopulmonary bypass decreases leukocyte count and activation of the complement system].
Bochenek A; Religa Z; Kokot F; Knapik P; Wnuk R; Komarski K; Wojnar J; Pietrzycki A; Skiba J
Kardiol Pol; 1992; 36(2):67-72. PubMed ID: 1583828
[TBL] [Abstract][Full Text] [Related]
8. Biocompatibility of leukocyte removal filters during leukocyte filtration of cardiopulmonary bypass perfusate.
Gu YJ; Obster R; Haan J; Gallandat Huet RC; Eijgelaar A; van Oeveren W
Artif Organs; 1993 Jul; 17(7):660-5. PubMed ID: 8338443
[TBL] [Abstract][Full Text] [Related]
9. Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass.
Hatori N; Yoshizu H; Haga Y; Kusama Y; Takeshima S; Segawa D; Tanaka S
Artif Organs; 1994 Dec; 18(12):904-10. PubMed ID: 7887827
[TBL] [Abstract][Full Text] [Related]
10. Respiratory dysfunction and white cell activation following cardiopulmonary bypass: comparison of membrane and bubble oxygenators.
Martin W; Carter R; Tweddel A; Belch J; el-Fiky M; McQuiston AM; McLaren M; Wheatley DJ
Eur J Cardiothorac Surg; 1996; 10(9):774-83. PubMed ID: 8905281
[TBL] [Abstract][Full Text] [Related]
11. Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass.
Noguchi M; Eishi K; Tada S; Yamachika S; Hazama S; Izumi K; Tanigawa K
Ann Thorac Cardiovasc Surg; 2003 Feb; 9(1):22-8. PubMed ID: 12667126
[TBL] [Abstract][Full Text] [Related]
12. Complement and leukocytes during cardiopulmonary bypass: effects on plasma C3d and C5a, leukocyte count, release of granulocyte elastase and granulocyte chemotaxis.
Knudsen F; Pedersen JO; Juhl O; Nielsen AH; Jersild C
J Cardiothorac Anesth; 1988 Apr; 2(2):164-70. PubMed ID: 17171907
[TBL] [Abstract][Full Text] [Related]
13. Reduced complement activation during cardiopulmonary bypass does not affect the postoperative acute phase response.
van den Goor J; Nieuwland R; van den Brink A; van Oeveren W; Rutten P; Tijssen J; Eijsman L
Eur J Cardiothorac Surg; 2004 Nov; 26(5):926-31. PubMed ID: 15519184
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass.
Ascione R; Lloyd CT; Underwood MJ; Lotto AA; Pitsis AA; Angelini GD
Ann Thorac Surg; 2000 Apr; 69(4):1198-204. PubMed ID: 10800819
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators.
Gillinov AM; Bator JM; Zehr KJ; Redmond JM; Burch RM; Ko C; Winkelstein JA; Stuart RS; Baumgartner WA; Cameron DE
Ann Thorac Surg; 1993 Oct; 56(4):847-53. PubMed ID: 8105757
[TBL] [Abstract][Full Text] [Related]
16. Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators.
Cavarocchi NC; Pluth JR; Schaff HV; Orszulak TA; Homburger HA; Solis E; Kaye MP; Clancy MS; Kolff J; Deeb GM
J Thorac Cardiovasc Surg; 1986 Feb; 91(2):252-8. PubMed ID: 3511328
[TBL] [Abstract][Full Text] [Related]
17. Biocompatibility of extracorporeal circulation with autooxygenation.
Bochenek A; Religa Z; Kokot F; Wnuk-Wojnar AM; Wojnar J; Wnuk R; Gallert G; Skiba J
Eur J Cardiothorac Surg; 1992; 6(8):397-402. PubMed ID: 1389244
[TBL] [Abstract][Full Text] [Related]
18. Biocompatibility of three different membrane oxygenators: effects on complement, neutrophil and monocyte activation.
de Vroege R; Rutten PM; Kalkman C; Out TA; Jansen PG; Eijsman L; de Mol BJ; Wildevuur CR
Perfusion; 1997 Nov; 12(6):369-75. PubMed ID: 9413849
[TBL] [Abstract][Full Text] [Related]
19. Plasma C3a and C5a concentrations during cardiopulmonary bypass.
Mastroroberto P; Chello M; Marchese AR
Ann Thorac Surg; 1994 Mar; 57(3):781-3. PubMed ID: 8147669
[No Abstract] [Full Text] [Related]
20. An alternative pathway for fibrinolysis is activated in patients who have undergone cardiopulmonary bypass surgery and major abdominal surgery.
Gando S; Kameue T; Sawamura A; Hayakawa M; Hoshino H; Kubota N
Thromb Res; 2007; 120(1):87-93. PubMed ID: 17023030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
